WallStreetZenWallStreetZen

NASDAQ: RNLX
Renalytix PLC Stock Ownership - Who owns Renalytix?

Insider buying vs selling

Have Renalytix PLC insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when RNLX insiders and whales buy or sell their stock.

RNLX Shareholders

What type of owners hold Renalytix PLC stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Christopher Mills10.08%10,072,500$8.36MInsider
James Renwick McCullough2.75%2,746,386$2.28MInsider
School Of Medicine At Mount Sinai Icahn2.33%2,331,239$1.93MInsider
O. James Sterling1.81%1,805,236$1.50MInsider
Cvi Holdings LLC1.15%1,144,305$949.77kInstitution
Gilder Gagnon Howe Co LLC0.88%879,451$729.94kInstitution
Pinnacle Associates Ltd0.85%846,534$702.62kInstitution
Pentwater Capital Management LP0.70%700,000$581.00kInstitution
Fergus Fleming0.57%569,481$472.67kInsider
Tejara Capital Ltd0.40%400,394$332.33kInstitution

1 of 3

RNLX vs Health Information Service Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RNLX4.96%17.67%
EUDA4.32%39.56%
NUTX2.03%97.97%Net Buying
BFRG0.75%33.18%Net SellingNet Selling
BEAT7.77%22.24%Net Selling

Renalytix Stock Ownership FAQ

Who owns Renalytix?

Renalytix (NASDAQ: RNLX) is owned by 4.96% institutional shareholders, 17.67% Renalytix insiders, and 77.37% retail investors. Christopher Mills is the largest individual Renalytix shareholder, owning 10.07M shares representing 10.08% of the company. Christopher Mills's Renalytix shares are currently valued at $7.91M.

If you're new to stock investing, here's how to buy Renalytix stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.